These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25358121)

  • 21. Bio Micro-Nano Technologies of Antioxidants Optimised Their Pharmacological and Cellular Effects, ex vivo, in Pancreatic β-Cells.
    Mooranian A; Zamani N; Mikov M; Goločorbin-Kon S; Stojanovic G; Arfuso F; Kovacevic B; Al-Salami H
    Nanotechnol Sci Appl; 2020; 13():1-9. PubMed ID: 32021126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study.
    Mooranian A; Raj Wagle S; Kovacevic B; Takechi R; Mamo J; Lam V; Watts GF; Mikov M; Golocorbin-Kon S; Stojanovic G; Al-Sallami H; Al-Salami H
    Sci Rep; 2020 Jan; 10(1):106. PubMed ID: 31919411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel, protective role of ursodeoxycholate in bile-induced pancreatic ductal injury.
    Katona M; Hegyi P; Kui B; Balla Z; Rakonczay Z; Rázga Z; Tiszlavicz L; Maléth J; Venglovecz V
    Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G193-204. PubMed ID: 26608189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatment.
    Mooranian A; Zamani N; Mikov M; Goločorbin-Kon S; Stojanovic G; Arfuso F; Al-Salami H
    Ther Deliv; 2019 Feb; 10(2):99-106. PubMed ID: 30729887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses.
    Mooranian A; Zamani N; Mikov M; Goločorbin-Kon S; Stojanovic G; Arfuso F; Al-Salami H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S741-S747. PubMed ID: 30260253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes.
    Mooranian A; Zamani N; Takechi R; Al-Sallami H; Mikov M; Goločorbin-Kon S; Kovacevic B; Arfuso F; Al-Salami H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S748-S754. PubMed ID: 30422681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment.
    Mooranian A; Negrulj R; Al-Sallami HS; Fang Z; Mikov M; Golocorbin-Kon S; Fakhoury M; Arfuso F; Al-Salami H
    J Microencapsul; 2015; 32(2):151-6. PubMed ID: 25265061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New fluorescent bile acids: synthesis, chemical characterization, and disastereoselective uptake by Caco-2 cells of 3-deoxy 3-NBD-amino deoxycholic and ursodeoxycholic acid.
    Májer F; Salomon JJ; Sharma R; Etzbach SV; Najib MN; Keaveny R; Long A; Wang J; Ehrhardt C; Gilmer JF
    Bioorg Med Chem; 2012 Mar; 20(5):1767-78. PubMed ID: 22316556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study.
    Mooranian A; Negrulj R; Mikov M; Golocorbin-Kon S; Arfuso F; Al-Salami H
    J Microencapsul; 2015; 32(6):589-97. PubMed ID: 26190214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alginate-combined cholic acid increased insulin secretion of microencapsulated mouse cloned pancreatic β cells.
    Mooranian A; Negrulj R; Takechi R; Jamieson E; Morahan G; Al-Salami H
    Ther Deliv; 2017 Oct; 8(10):833-842. PubMed ID: 28944743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of ursodeoxycholic acid on liver mitochondrial function in rats with alloxan-induced diabetes: link with oxidative stress.
    Lukivskaya O; Patsenker E; Buko VU
    Life Sci; 2007 Jun; 80(26):2397-402. PubMed ID: 17512017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Biotechnological Processes, Speed of Formulation Flow and Cellular Concurrent Stream-Integration on Insulin Production from β-cells as a Result of Co-Encapsulation with a Highly Lipophilic Bile Acid.
    Mooranian A; Negrulj R; Takechi R; Jamieson E; Morahan G; Al-Salami H
    Cell Mol Bioeng; 2018 Feb; 11(1):65-75. PubMed ID: 31719879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of water-soluble prodrugs of ursodeoxycholic acid (UDCA), an anti-apoptotic bile acid.
    Dosa PI; Ward T; Castro RE; Rodrigues CM; Steer CJ
    ChemMedChem; 2013 Jun; 8(6):1002-11. PubMed ID: 23640741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
    Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
    Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer.
    Mooranian A; Negrulj R; Chen-Tan N; Watts GF; Arfuso F; Al-Salami H
    Drug Des Devel Ther; 2014; 8():1673-83. PubMed ID: 25302020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protective effect of ursodeoxycholic acid in alloxan-induced diabetes.
    Lukivskaya O; Lis R; Egorov A; Naruta E; Tauschel HD; Buko VU
    Cell Biochem Funct; 2004; 22(2):97-103. PubMed ID: 15027098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of mitochondria in cell death induced by Photofrin-PDT and ursodeoxycholic acid by means of SLIM.
    Kinzler I; Haseroth E; Hauser C; Rück A
    Photochem Photobiol Sci; 2007 Dec; 6(12):1332-40. PubMed ID: 18046490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis.
    Rolo AP; Palmeira CM; Holy JM; Wallace KB
    Toxicol Sci; 2004 May; 79(1):196-204. PubMed ID: 14976352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes.
    Azzaroli F; Mehal W; Soroka CJ; Wang L; Lee J; Crispe IN; Boyer JL
    Hepatology; 2002 Jul; 36(1):49-54. PubMed ID: 12085348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes.
    Negrulj R; Mooranian A; Chen-Tan N; Al-Sallami HS; Mikov M; Golocorbin-Kon S; Fakhoury M; Watts GF; Arfuso F; Al-Salami H
    Artif Cells Nanomed Biotechnol; 2016 Aug; 44(5):1290-7. PubMed ID: 25811999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.